Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200020/S012

Clearview 3

Lenstec, Inc. · Decision date Apr 15, 2026

FDA DECISIONP200020/S012

What did the FDA decide?

FDA records P200020/S012 as a supplement to PMA P200020, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 15, 2026.

FDA approval order statement

the addition of a new moist heat (steam) sterilizer, and associated increased maximum sterilization load size, for routine terminal sterilization of the subject intraocular lens devices
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Apr 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P200020/S012
Regulatory pathway
PMA supplement
Applicant
Lenstec, Inc.
Product code
MFK
Decision code
OK30
Decision date
Apr 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Applicant
Lenstec, Inc.
Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P200020. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200020 · Original PMA

    SBL-3 Multifocal Intraocular Lens

  2. P200020/S012 received

    Application receipt date recorded by FDA.

  3. P200020/S012 · FDA decision

    30-Day Notice

  4. P200020/S013 · Related supplement

    ClearView HD intraocular lens (IOL)

Timeline entries are records held by MedtechLedger for P200020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200020

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA approvalJul 22, 2022FDA
ClearView 3 LensP200020/S009
Lenstec, Inc.PMA supplementAug 12, 2025FDA
ClearView 3P200020/S010
Lenstec, Inc.PMA supplementDec 4, 2025FDA
ClearView 3 IOLP200020/S011
Lenstec, Inc.PMA supplementMar 25, 2026FDA
Lenstec, Inc.PMA supplementOct 23, 2026FDA

Explore the linked device profile

Other records with product code MFK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lenstec, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1765 Commerce Ave. N, St. Petersburg, FL, 33716

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records